Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Medical Research Methodology|May 26, 2025
Development of time to event prediction models using federated learningRasmus Rask Kragh Jørgensen, Jonas Faartoft Jensen, Tarec El-Galaly, et al.
European Journal of Haematology|March 30, 2026
Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population-Based StudyMads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen, et al.
Haematologica|April 24, 2025
A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphomaKjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, et al.
Haematologica|June 12, 2025
Response to Comment on: A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphomaKjersti Lia, Rasmus Rask Kragh Jørgensen, Per Wikman, et al.
Clinical Epidemiology|March 19, 2024
Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort StudyEva Futtrup Maksten, Rasmus Rask Kragh Jørgensen, Mathilde Selmar Pedersen, et al.
Blood Advances|May 22, 2025
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell LymphomaLeo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen, et al.
European Journal of Haematology|July 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based studyRasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, et al.
Blood Advances|December 19, 2023
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trialMats Jerkeman, Arne Kolstad, Martin Hutchings, et al.
European Journal of Haematology|December 8, 2025
Validation of US Consensus Eligibility Criteria for Front-Line DLBCL TrialsJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Annals of Hematology|December 31, 2024
Validation of prognostic models in elderly patients with diffuse large B-cell lymphoma in a real-world nationwide population-based study - development of a clinical nomogramJelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, et al.
Pageof 2